FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092089228> ?p ?o ?g. }

• W3092089228 endingPage "e276" @default.
• W3092089228 startingPage "e267" @default.
• W3092089228 abstract "Morvan syndrome is characterized by central, autonomic, and peripheral hyperexcitability due to contactin-associated protein 2 (CASPR2) antibody. Our objective was to study the clinical spectrum, electrophysiologic, autonomic, polysomnographic, and neuropsychological profile in patients with CASPR2-related Morvan syndrome.Serum and CSF samples that were CASPR2 antibody positive from 2016 to 2019 were assessed. Among them, patients with Morvan syndrome diagnosed based on clinical and electrophysiologic basis were included.Fourteen (M:F = 10:4) patients with Morvan syndrome were included with age at onset of 37.1 ± 17.5 years. The clinical features were muscle twitching (12), insomnia (12), pain (11), paresthesias (9), hyperhidrosis (7), hypersalivation (6), double incontinence (3), spastic speech (2), dysphagia (2), behavioral disturbances (2), seizures (1), and cold intolerance (1). Neurologic examination revealed myokymia (12), hyperactive tendon reflexes (10), and tremor (6). EMG revealed neuromyotonia (12) and increased spontaneous activity (7). Autonomic function tests conducted in 8 patients revealed definite autonomic dysfunction (4), orthostatic hypotension (2), early dysfunction (1), and postural orthostatic tachycardia syndrome (1). Polysomnography findings in 6 patients revealed insomnia (3), absence of deep sleep (1), high-frequency beta activity (1), REM behavior disorder (1), and periodic leg movements (1). Neuropsychological evaluation showed subtle involvement of the left frontal and temporal lobe. Malignancy workup was negative. All patients were treated with steroids. There was complete neurologic resolution in follow-up with persistent neuropathic pain in 5 patients.This study has contributed to the growing knowledge on CASPR2-related Morvan syndrome. It is important for an increased awareness and early recognition as it is potentially treatable by immunotherapy." @default.
• W3092089228 created "2020-10-15" @default.
• W3092089228 creator A5006776113 @default.
• W3092089228 creator A5007426632 @default.
• W3092089228 creator A5018128187 @default.
• W3092089228 creator A5026530949 @default.
• W3092089228 creator A5032566235 @default.
• W3092089228 creator A5035713109 @default.
• W3092089228 creator A5039469707 @default.
• W3092089228 creator A5051924854 @default.
• W3092089228 creator A5054892321 @default.
• W3092089228 creator A5056673079 @default.
• W3092089228 creator A5057025551 @default.
• W3092089228 creator A5057448159 @default.
• W3092089228 creator A5058083198 @default.
• W3092089228 creator A5067537574 @default.
• W3092089228 creator A5083107758 @default.
• W3092089228 date "2020-10-06" @default.
• W3092089228 modified "2023-10-06" @default.
• W3092089228 title "CASPR2-Related Morvan Syndrome" @default.
• W3092089228 cites W145139182 @default.
• W3092089228 cites W1579742067 @default.
• W3092089228 cites W1980627145 @default.
• W3092089228 cites W1983329560 @default.
• W3092089228 cites W1988209063 @default.
• W3092089228 cites W1995608828 @default.
• W3092089228 cites W2001066724 @default.
• W3092089228 cites W2003579649 @default.
• W3092089228 cites W2009952087 @default.
• W3092089228 cites W2030651245 @default.
• W3092089228 cites W2037312720 @default.
• W3092089228 cites W2063577571 @default.
• W3092089228 cites W2065444697 @default.
• W3092089228 cites W2076805831 @default.
• W3092089228 cites W2088194756 @default.
• W3092089228 cites W2102218110 @default.
• W3092089228 cites W2107223890 @default.
• W3092089228 cites W2134389315 @default.
• W3092089228 cites W2135857555 @default.
• W3092089228 cites W2165392739 @default.
• W3092089228 cites W2285072859 @default.
• W3092089228 cites W2460556795 @default.
• W3092089228 cites W2502994078 @default.
• W3092089228 cites W2507374250 @default.
• W3092089228 cites W2565506715 @default.
• W3092089228 cites W2578164715 @default.
• W3092089228 cites W2593828537 @default.
• W3092089228 cites W2756731354 @default.
• W3092089228 cites W2766065003 @default.
• W3092089228 cites W2886173277 @default.
• W3092089228 cites W2915334911 @default.
• W3092089228 cites W4298441315 @default.
• W3092089228 cites W2418310762 @default.
• W3092089228 doi "https://doi.org/10.1212/cpj.0000000000000978" @default.
• W3092089228 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8382356" @default.
• W3092089228 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34484901" @default.
• W3092089228 hasPublicationYear "2020" @default.
• W3092089228 type Work @default.
• W3092089228 sameAs 3092089228 @default.
• W3092089228 citedByCount "7" @default.
• W3092089228 countsByYear W30920892282021 @default.
• W3092089228 countsByYear W30920892282022 @default.
• W3092089228 countsByYear W30920892282023 @default.
• W3092089228 crossrefType "journal-article" @default.
• W3092089228 hasAuthorship W3092089228A5006776113 @default.
• W3092089228 hasAuthorship W3092089228A5007426632 @default.
• W3092089228 hasAuthorship W3092089228A5018128187 @default.
• W3092089228 hasAuthorship W3092089228A5026530949 @default.
• W3092089228 hasAuthorship W3092089228A5032566235 @default.
• W3092089228 hasAuthorship W3092089228A5035713109 @default.
• W3092089228 hasAuthorship W3092089228A5039469707 @default.
• W3092089228 hasAuthorship W3092089228A5051924854 @default.
• W3092089228 hasAuthorship W3092089228A5054892321 @default.
• W3092089228 hasAuthorship W3092089228A5056673079 @default.
• W3092089228 hasAuthorship W3092089228A5057025551 @default.
• W3092089228 hasAuthorship W3092089228A5057448159 @default.
• W3092089228 hasAuthorship W3092089228A5058083198 @default.
• W3092089228 hasAuthorship W3092089228A5067537574 @default.
• W3092089228 hasAuthorship W3092089228A5083107758 @default.
• W3092089228 hasBestOaLocation W30920892282 @default.
• W3092089228 hasConcept C126322002 @default.
• W3092089228 hasConcept C164705383 @default.
• W3092089228 hasConcept C2778205975 @default.
• W3092089228 hasConcept C2778650131 @default.
• W3092089228 hasConcept C2781326671 @default.
• W3092089228 hasConcept C42219234 @default.
• W3092089228 hasConcept C71924100 @default.
• W3092089228 hasConcept C73787029 @default.
• W3092089228 hasConcept C84393581 @default.
• W3092089228 hasConceptScore W3092089228C126322002 @default.
• W3092089228 hasConceptScore W3092089228C164705383 @default.
• W3092089228 hasConceptScore W3092089228C2778205975 @default.
• W3092089228 hasConceptScore W3092089228C2778650131 @default.
• W3092089228 hasConceptScore W3092089228C2781326671 @default.
• W3092089228 hasConceptScore W3092089228C42219234 @default.
• W3092089228 hasConceptScore W3092089228C71924100 @default.
• W3092089228 hasConceptScore W3092089228C73787029 @default.
• W3092089228 hasConceptScore W3092089228C84393581 @default.

• next